Top Markets
Coin of the day
Advanced BioMedical Technologies Inc. Advanced BioMedical Technologies Inc.

Advanced BioMedical Technologies Inc.

ABMT
Rangering i aksjer #41027
Advanced Biomedical Technologies, Inc., a development stage company, designs,... Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
Aksjekurs
$0.0005
Sist synkronisert: 2026-08-12
Markedsverdi
$50.00K
Endring (1 dag)
0.00%
Endring (1 år)
400.00%
Land
US
Handel Advanced BioMedical Technologies Inc. (ABMT)

Kategori

Driftsmargin for Advanced BioMedical Technologies Inc. (ABMT)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Advanced BioMedical Technologies Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Advanced BioMedical Technologies Inc. fra 2026 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
Ikke nok data for de angitte datoene.
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
28.09% -
US
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.